Breast cancer treatment regimen

Details for Australian Patent Application No. 2004281527 (hide)

Owner Novartis AG

Inventors Goss, Paul E

Agent Davies Collison Cave

Pub. Number AU-A-2004281527

PCT Pub. Number WO2005/037263

Priority 10/681,913 09.10.03 US

Filing date 8 October 2004

Wipo publication date 28 April 2005

International Classifications

A61K 31/56 (2006.01) - Compounds containing cyclopenta[a]hydrophenanthrene ring systems

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/4178 (2006.01)

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/037263 Priority application(s): WO2005/037263

18 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281528-Coated fat-based confectionery products

2004281525-The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin